Actuate Therapeutics, Inc.
ACTUNasdaqCIK 1652935HealthcareFiscal year ends Dec 31
All transactions: 1
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-28 | Schmitt Daniel MPresident, CEO and Director, Director, Officer | Purchase | 140,844 | $0.355 | $50.0k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 17:14 ET. Listed shows no prices and gives no investment advice.